What is Matrixyl (palmitoyl pentapeptide)?
Matrixyl is a pentapeptide derived from a collagen fragment (KTTKS), coupled to a fatty acid (palmitic acid) to improve skin penetration. It is meant to act as a messenger that prompts fibroblasts to produce collagen and other connective-tissue components. On the cosmetics market since 2000.
How well studied is Matrixyl (palmitoyl pentapeptide)?
Besides lab data (collagen production in fibroblasts) there are small clinical studies, e.g. Robinson et al. (2005) on photoaged facial skin, reporting improvements; the effects are considered modest. Part of the data comes from the manufacturer; large independent long-term studies are lacking.
What side effects and risks does Matrixyl (palmitoyl pentapeptide) have?
Considered well tolerated; redness, stinging or contact allergy are possible, often due to other formulation ingredients. Effects are cosmetic and small – do not expect results like medical treatments.
Is Matrixyl (palmitoyl pentapeptide) approved in Germany?
In short: no. Not a medicine but a cosmetic ingredient (EU Cosmetics Regulation). According to USADA, palmitoyl pentapeptide-4/-3 is among the non-prohibited cosmetic peptides. Marketing claims (“like Botox”, “lifting”) are not supported by studies.
Sources
Note: We deliberately do not list any doses here. For approved medicines, your doctor sets the dose; for unapproved substances there is no reliable information.